Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma. (HealthDay News) — Neoantigen-targeting personalized ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Initially diagnosed with a tumor on her right kidney, Mazey underwent surgery to remove the tumor and her kidney before the cancer returned, this time attacking her lungs.

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

In a written response to a question in the Lok Sabha, Nadda revealed that 57,184 women were diagnosed with breast cancer, with 50,612 currently undergoing treatment. Additionally, 96,747 women ...

Practice-changing result “The KEYNOTE-564 study’s update, highlighting pembrolizumab’s efficacy in the adjuvant setting post-kidney cancer surgery, marks a significant development in ...

THERE are more than 200 different types of cancer that can cause ... persistent lumps or swelling, particularly in the neck, armpit, stomach, groin, chest, breast or testicle, should be taken ...

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

It may cause mild side effects, such as abdominal pain ... Note that Ozempic has a boxed warning about the risk of thyroid cancer. A boxed warning is the most serious warning from the Food ...

Li et al. show that the TFE3 driver fusion transcriptionally upregulates an OXPHOS programme in translocation renal cell carcinoma that renders this cancer vulnerable to reductive stress ...